Candidate Selection for Durable Mechanical Circulatory Support.

Area of Science:

• Cardiology
• Medical Devices
• Surgical Techniques

Background:

• Severe systolic dysfunction and heart failure symptoms are associated with significant morbidity and mortality.
• While medical management is primary, mechanical circulatory support (MCS) is an option for end-stage heart failure.
• The left ventricular assist device (LVAD) is the most common durable MCS.

Purpose of the Study:

• To highlight the advancements in LVAD technology, surgical techniques, and patient management.
• To emphasize the complexity of risk assessment in LVAD candidates.
• To underscore the necessity of comprehensive risk evaluation in the decision-making process for MCS.

Main Methods:

• Review of current literature on LVADs and mechanical circulatory support.
• Analysis of factors influencing risk in patients with end-stage heart failure.
• Discussion of the limitations of existing risk assessment models.

Main Results:

• Significant improvements have been made in LVAD technology, surgical procedures, and patient care.
• No single model can accurately predict risk due to the multitude of variables involved.
• Comprehensive risk assessment is essential for optimal patient selection and management.

Conclusions:

• LVADs represent a vital treatment option for end-stage heart failure.
• Accurate and thorough risk assessment is paramount for successful LVAD implantation and patient outcomes.
• Further development in risk stratification models may be beneficial.